查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲顯影劑與注射器系統市場：分析與預測（2022-2026）
市場調查報告書
商品編碼
1439032

歐洲顯影劑與注射器系統市場：分析與預測（2022-2026）

Europe Contrast Media Agent and Injector System Market: Analysis and Forecast: 2022-2026
出版日期: | 出版商: BIS Research | 英文 94 Pages | 商品交期: 1-5個工作天內

價格

歐洲顯影劑和注射系統市場規模預計將從 2022 年的 21.415 億美元成長到 2026 年的 27.406 億美元，預測期內複合年成長率為 6.36%。

歐洲顯影劑和注射器系統市場：簡介

主要市場統計數據
預測期 2022-2026
2022年評估 21.415 億美元
2026年預測 27.406 億美元
複合年成長率 6.36%

在慢性病的增加、診斷影像需求的增加以及醫學影像技術的進步等因素的推動下，歐洲顯影劑和注射系統市場正在經歷強勁成長。顯影劑和注射器系統在提高電腦斷層掃描、MRI 掃描和血管造影術等診斷影像中解剖結構的可見度方面發揮著重要作用。隨著社會老化和醫療費用的增加，疾病的早期發現和準確診斷變得越來越重要，歐洲對顯影劑和注射系統的需求不斷增加。此外，旨在改善診斷影像技術和患者預後的研發正在取得進展，預計將成為市場成長的驅動力。旨在確保患者安全和提供創新成像解決方案的監管措施也促進了該地區的市場成長。

本報告調查了歐洲顯影劑和注射系統市場，總結了市場概況、法律制度、專利趨勢、市場影響因素分析、市場規模趨勢和預測、競爭形勢以及主要企業分析。

市場分類

細分 1：依產品分類

  • 顯影劑
  • 注射系統

細分：噴射器系統（依產品）

  • 注射器
  • 耗材/配件

細分 2：按國家/地區

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他

目錄

執行摘要

調查範圍

第1章 市場

  • 市場展望
    • 產品定義
    • 涵蓋與排除標準
    • 主要發現
  • 市場概況
  • 產業展望
    • 監管和法律要求及框架
    • 專利分析
    • 主要趨勢
  • COVID-19 對顯影劑和注射器系統市場的影響
  • 市場動態
    • 影響分析
    • 市場促進因素
    • 市場限制因素
    • 市場機會

第2章 區域

  • 概述
  • 歐洲
    • 主要發現
    • 市場動態
    • 市場規模/預測

第3章市場－競爭基準化分析與公司概況

  • 競爭基準化分析
    • 主要策略及發展
    • 市場佔有率分析
  • 顯影劑生態系中的活躍公司
  • 公司簡介
    • Bayer AG
    • Bracco Group
    • Fresenius SE & Co. KGaA
    • Guerbet
    • ulrich GmbH & Co. KG
Product Code: BHR1891SS

The Europe Contrast Media Agent and Injector System Market Expected to Reach $2,740.6 Million by 2026

Introduction to Europe Contrast Media Agent and Injector System Market

KEY MARKET STATISTICS
Forecast Period2022 - 2026
2022 Evaluation$2,141.5 Million
2026 Forecast$2,740.6 Million
CAGR6.36%

The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026. The market is driven due to factors like rising cases of cancer and cardiovascular diseases, which result in higher demand for contrast media agents, injector systems, and image-guided diagnostic procedures.

Market Introduction

The Europe Contrast Media Agent and Injector System market is witnessing robust growth driven by factors such as the increasing prevalence of chronic diseases, rising demand for diagnostic imaging procedures, and advancements in medical imaging technologies. Contrast media agents and injector systems play a crucial role in enhancing the visibility of anatomical structures during imaging procedures such as CT scans, MRI scans, and angiography. With a growing aging population and rising healthcare expenditures, there is a heightened emphasis on early disease detection and accurate diagnosis, further fueling the demand for contrast media agents and injector systems in Europe. Additionally, ongoing research and development activities aimed at improving imaging techniques and patient outcomes are expected to drive market growth. Regulatory initiatives aimed at ensuring patient safety and the availability of innovative imaging solutions also contribute to market expansion in the region.

Market Segmentation:

Segmentation 1: by Product

  • Contrast Media Agents
  • Injector Systems

Segmentation: Injector Systems (by Product)

  • Injector
  • Consumables and Accessories

Segmentation 2: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Growth/Marketing Strategy: The Europe contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

Competitive Strategy: The Europe contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies can expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Some of the prominent names established in this market are:

  • Bayer AG
  • Bracco Group
  • Guerbet
  • ulrich GmbH & Co. KG

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1 Markets

  • 1.1 Market Outlook
    • 1.1.1 Product Definition
    • 1.1.2 Inclusion and Exclusion Criteria
    • 1.1.3 Key Findings
  • 1.2 Market Overview
  • 1.3 Industry Outlook
    • 1.3.1 Regulatory and Legal Requirements and Framework
      • 1.3.1.1 Regulatory and Legal Requirements and Framework in Europe
    • 1.3.2 Patent Analysis
      • 1.3.2.1 Patent Filing Trend (by Year)
      • 1.3.2.2 Patent Filing Trend (by Country)
    • 1.3.3 Key Trends
      • 1.3.3.1 Nanoparticle-Based Contrast Agents
      • 1.3.3.2 Development of Safer Contrast Media Agent
      • 1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
  • 1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
    • 1.4.1 Pre-COVID-19 Impact
    • 1.4.2 During COVID-19 Impact
    • 1.4.3 Post-COVID-19 Impact
  • 1.5 Market Dynamics
    • 1.5.1 Impact Analysis
    • 1.5.2 Market Drivers
      • 1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
      • 1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
      • 1.5.2.3 Growing Number of Regulatory Approvals
    • 1.5.3 Market Restraints
      • 1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
    • 1.5.4 Market Opportunities
      • 1.5.4.1 IT Advances in Contrast Media Injectors

2 Region

  • 2.1 Overview
  • 2.2 Europe
    • 2.2.1 Key Findings
    • 2.2.2 Market Dynamics
      • 2.2.2.1 Impact Analysis
    • 2.2.3 Market Size and Forecast
      • 2.2.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
        • 2.2.3.1.1 Europe Contrast Media Injector System Market (by Product)
      • 2.2.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
        • 2.2.3.2.1 Germany
          • 2.2.3.2.1.1 Market Sizing and Forecast
          • 2.2.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
        • 2.2.3.2.2 Italy
          • 2.2.3.2.2.1 Market Sizing and Forecast
          • 2.2.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
        • 2.2.3.2.3 France
          • 2.2.3.2.3.1 Market Sizing and Forecast
          • 2.2.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
        • 2.2.3.2.4 U.K.
          • 2.2.3.2.4.1 Market Sizing and Forecast
          • 2.2.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
        • 2.2.3.2.5 Spain
          • 2.2.3.2.5.1 Market Sizing and Forecast
          • 2.2.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
        • 2.2.3.2.6 Rest-of-Europe
          • 2.2.3.2.6.1 Market Sizing and Forecast
          • 2.2.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
          • 2.2.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Benchmarking
    • 3.1.1 Key Strategies and Development
      • 3.1.1.1 Regulatory and Legal Activities
      • 3.1.1.2 Partnerships, Collaborations, and Business Expansions
      • 3.1.1.3 Mergers and Acquisitions
      • 3.1.1.4 New Offerings
    • 3.1.2 Market Share Analysis
      • 3.1.2.1 Market Share Analysis, by Contrast Media Agent Market
      • 3.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
  • 3.2 Contrast Media Ecosystem Active Players
  • 3.3 Company Profiles
    • 3.3.1 Bayer AG
      • 3.3.1.1 Company Overview
      • 3.3.1.2 Role of Bayer AG in the Contrast Media Agent and Injector System Market
      • 3.3.1.3 Financials
      • 3.3.1.4 Recent Developments
      • 3.3.1.5 Analyst Perception
    • 3.3.2 Bracco Group
      • 3.3.2.1 Company Overview
      • 3.3.2.2 Role of Bracco Group in the Contrast Media Agent and Injector System Market
      • 3.3.2.3 Recent Developments
      • 3.3.2.4 Analyst Perception
    • 3.3.3 Fresenius SE & Co. KGaA
      • 3.3.3.1 Company Overview
      • 3.3.3.2 Role of Fresenius SE & Co. KGaA in the Contrast Media Agent and Injector System Market
      • 3.3.3.3 Financials
      • 3.3.3.4 Recent Developments
      • 3.3.3.5 Analyst Perception
    • 3.3.4 Guerbet
      • 3.3.4.1 Company Overview
      • 3.3.4.2 Role of Guerbet in the Contrast Media Agent and Injector System Market
      • 3.3.4.3 Financials
      • 3.3.4.4 Recent Developments
      • 3.3.4.5 Analyst Perception
    • 3.3.5 ulrich GmbH & Co. KG
      • 3.3.5.1 Company Overview
      • 3.3.5.2 Role of ulrich GmbH & Co. KG in the Contrast Media Agent and Injector System Market
      • 3.3.5.3 Recent Developments
      • 3.3.5.4 Analyst Perception

List of Figures

  • Figure 1: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 2: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 3: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021 and 2026
  • Figure 4: Contrast Media Agent and Injector System Market: Research Methodology
  • Figure 5: Primary Research Methodology
  • Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 8: Contrast Media Agent and Injector System Market, Patent Analysis (by Year), January 2018-May 2022
  • Figure 9: Contrast Media Agent and Injector System Market, Patent Analysis (by Country), January 2018-May 2022
  • Figure 10: Number of CT Scans Per One Million Inhabitants in the U.S., 2015, 2017, and 2019
  • Figure 11: Number of CT Scans Per One Million Inhabitants in Europe (by Country), 2015, 2017, and 2019
  • Figure 12: Number of CT Scans Per One Million Inhabitants in Asia-Pacific (by Country), 2015, 2017, and 2019
  • Figure 13: Number of CT Scans Per One Million Inhabitants, 2018-2020
  • Figure 14: Number of Scans by Imaging Modalities in the U.K. from 2018-2019 to 2020-2021, Million
  • Figure 15: Contrast Media Agent and Injector System Market, Impact Analysis
  • Figure 16: Expected Number of Cancer Cases, Globally, 2020, 2025, 2030, 2035, and 2040
  • Figure 17: Incidence of Cardiovascular Disease, 2015 - 2019, Million
  • Figure 18: Innovative Vendors Product Solutions
  • Figure 19: Contrast Media Agent and Injector System Market (by Region), % Share, 2021-2026
  • Figure 20: Europe Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 21: Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 22: Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 23: Europe Contrast Media Agent and Injector System Market (by Country), % Share, 2021 and 2026
  • Figure 24: Germany Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 25: Germany Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 26: Germany Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 27: Italy Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 28: Italy Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 29: Italy Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 30: France Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 31: France Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 32: France Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 33: Number of Scans by Imaging Modalities in the U.K. from 2015-2016 to 2020-2021, Million
  • Figure 34: U.K. Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 35: U.K. Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 36: U.K. Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 37: Number of CT Scanners in Spain per One Million Inhabitants, 2014-2020
  • Figure 38: Spain Contrast Media Agent and Injector System Market, $Million, 2021-2026
  • Figure 39: Spain Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 40: Spain Contrast Media and Injector System Market (by Product), $Million, 2021-2026
  • Figure 41: Rest-of-Europe Contrast Media Agent and Injector System Market, $Million, 2022-2026
  • Figure 42: Rest-of-Europe Contrast Media Agent and Injector System Market (by Product), $Million, 2021-2026
  • Figure 43: Rest-of-Europe Contrast Media Injector System Market (by Product), $Million, 2021-2026
  • Figure 44: Contrast Media Agent and Injector System Market, Number of Key Developments and Strategies, January 2018-May 2023
  • Figure 45: Regulatory and Legal Activities, January 2018-May 2023
  • Figure 46: Partnerships, Collaborations, and Business Expansions, January 2018-May 2023
  • Figure 47: Mergers and Acquisitions, January 2018-May 2023
  • Figure 48: New Offerings, January 2018-May 2023
  • Figure 49: Contrast Media Agent Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 50: Contrast Media Injector System Market, Company Revenue Share Analysis, $Million, 2021
  • Figure 51: Bayer AG: Product Portfolio
  • Figure 52: Bayer AG: Overall Financials, $Million, 2020-2022
  • Figure 53: Bayer AG: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 54: Bayer AG: Net Revenue (by Region), $Million, 2020-2022
  • Figure 55: Bayer AG: R&D Expenditure, $Million, 2020-2022
  • Figure 56: Bracco Group: Product Portfolio
  • Figure 57: Fresenius SE & Co. KGaA: Product Portfolio
  • Figure 58: Fresenius SE & Co. KGaA: Overall Financials, $Million, 2020-2022
  • Figure 59: Fresenius SE & Co. KGaA: Net Revenue (by Region), $Million, 2020-2022
  • Figure 60: Fresenius SE & Co. KGaA: R&D Expenditure, $Million, 2020-2022
  • Figure 61: Guerbet: Product Portfolio
  • Figure 62: Guerbet: Overall Financials, $Million, 2020-2022
  • Figure 63: Guerbet: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 64: ulrich GmbH & Co. KG: Product Portfolio

List of Tables

  • Table 1: Contrast Media Agent and Injector System Market, Key Developments Analysis, January 2018-May 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Contrast Media Agent and Injector System Market, Partnerships and Business Alliances, January 2018-May 2023
  • Table 4: Some of the Regulatory Approvals in Contrast Media Agent and Injector System Market, 2019-2023
  • Table 5: Some of the Contrast Media Reactions and Effects
  • Table 6: Guidelines for Contrast Administration and Hydration
  • Table 7: Europe Contrast Media Agent and Injector System Market, Impact Analysis
  • Table 8: Contrast Media Ecosystem Active Players